VAM
PFE icon

Visium Asset Management’s Pfizer PFE Stock Holding History

Visium Asset Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-7,378
Closed -$247K – 150
2016
Q2 		$247K Sell
7,378
-2,254,940
-100% -$72M 0.02% 302
2016
Q1 		$63.6M Buy
2,262,318
+513,189
+29% +$14.7M 1.08% 13
2015
Q4 		$53.6M Buy
1,749,129
+708,111
+68% +$22.3M 0.8% 21
2015
Q3 		$31M Buy
1,041,018
+801,700
+335% +$25.7M 0.42% 45
2015
Q2 		$7.61M Sell
239,318
-168,026
-41% -$5.48M 0.11% 202
2015
Q1 		$13.4M Sell
407,344
-80,721
-17% -$2.57M 0.2% 106
2014
Q4 		$14.4M Buy
488,065
+282,961
+138% +$8.11M 0.2% 89
2014
Q3 		$5.75M Buy
+205,104
New +$5.76M 0.09% 243
2014
Q1 		– Sell
-23,589
Closed -$685K – 990
2013
Q4 		$685K Sell
23,589
-294,556
-93% -$8.57M 0.01% 524
2013
Q3 		$8.67M Sell
318,145
-281,586
-47% -$7.66M 0.2% 87
2013
Q2 		$15.9M Buy
+599,731
New +$16.6M 0.37% 55

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Visium Asset Management's PFE Position: Q3 2016 in Review

Visium Asset Management sold out of Pfizer (PFE) in Q3 2016, closing a stake of 7,378 shares — an estimated $247K sold.

Visium Asset Management first reported a position in PFE in Q2 2013 and held it in 11 quarters. The position peaked at $63.6M in Q1 2016. 1,963 funds tracked by Wall St. Rank hold PFE as of Q3 2016.

  • Visium Asset Management reported no remaining Pfizer position as of Q3 2016 after selling out during the quarter.
  • Visium Asset Management sold 7,378 Pfizer shares in Q3 2016, an estimated $247K.
  • Visium Asset Management first reported a position in Pfizer in Q2 2013 and held it in 11 quarters.
  • Visium Asset Management's Pfizer position peaked at $63.6M in Q1 2016.
  • 1,963 funds tracked by Wall St. Rank held Pfizer as of Q3 2016.

Based on Visium Asset Management's 13F filing for Q3 2016.